Dopamine


Article Author:
James Sonne


Article Editor:
Wilfredo Lopez-Ojeda


Editors In Chief:
Stephen Leslie
Karim Hamawy


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Trevor Nezwek
Radia Jamil
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Steve Bhimji
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Nazia Sadiq
Hajira Basit
Phillip Hynes
Tehmina Warsi


Updated:
5/3/2019 9:58:26 AM

Indications

Dopamine (DA) is a peripheral vasostimulant used to treat low blood pressure, low heart rate, and cardiac arrest, especially in acute neonatal cases via a continuous intravenous drip.[1]  Low infusion rates (0.5 to 2 micrograms/kg per minute) act on the visceral vasculature to produce vasodilation including the kidneys, resulting in increased urinary flow.  Intermediate infusion rates (from 2 to 10 micrograms/kg/min) stimulate myocardial contractility and increase electrical conductivity in the heart leading to increased cardiac output.  Higher doses cause vasoconstriction and increased blood pressure via the adrenergic receptors alpha-1, beta-1, and beta-2, which can lead to poor peripheral circulation.[2]   

DA is often indicated to maintain blood pressure for chronic congestive heart failure, trauma, renal failure, and even open-heart surgery and shock from myocardial infarction or septicemia. DA administration in low doses may also be beneficial to manage hypotension, low cardiac output, and inadequate organ perfusion (often indicated by low urine production). In the central nervous system (CNS), DA gained significant clinical importance after Hornykiewicz's experiments showed its reduction within the caudate nucleus of patients with Parkinson's disease. Furthermore, the intravenous administration of its amino acid precursor, L-DOPA (L-dihydroxyphenylalanine), attenuated the Parkinsonian symptoms.[3] Since the blood-brain barrier prohibits the crossing of DA into the CNS from the systemic circulation, DA is ineffective on central neurological deficits such as Parkinson's disease. However, L-DOPA successfully crosses the blood-brain barrier and can be administered systemically, including oral pills. Although the therapeutic replacement of dopamine is effective alleviating motor symptoms, it may lead to motor side-effects and behavioral issues associated with addiction (i.e., impulse control disorders.)[4]

Mechanism of Action

DA biosynthesis occurs following the same enzymatic sequence as norepinephrine (NE). In fact, DA is a precursor in the synthesis of NE (see Figure).[5][6] The first step of DA synthesis is rate-limiting and involves the conversion of L-tyrosine to L-DOPA by the enzyme tyrosine hydroxylase (TH) enzyme.[7][8][9] This conversion requires oxygen, an iron co-factor and tetrahydrobiopterin(BH4 or THB), and results in the adding of a hydroxyl group to the aromatic ring to form L-DOPA. This is subsequently converted to DA by the aromatic L-amino acid decarboxylase, involving the removal of the carboxyl group. Once synthesized, DA is transported into synaptic vesicles via the vesicular monoamine transporter 2 (VMAT2) to the synaptic terminals.[10][11][12] 

If L-tyrosine is regularly consumed in abundance, it readily crosses the blood-brain barrier as does L-DOPA.[13]. But its utility is restricted spatially because DA cannot cross the blood-brain barrier. However, if L-tyrosine levels are low, L-phenylalanine may be converted into L-tyrosine by phenylalanine hydroxylase.

After DA is released into the synaptic space, it interacts with various receptors on the pre- and post-synaptic terminals causing neuronal excitation or inhibition at the target neuron. There are two entire families of DA receptors composed of five different isoforms, each of which affects different intracellular signaling pathways.[14] Both families of dopamine receptors, D1 and D2, are by definition G-protein-coupled receptors, but the D1 receptor class results in the neuron's depolarization, whereas the D2 receptors inhibit neuronal firing.[15]

Once in the synaptic cleft, DA is transported back into the pre-synaptic neuron via DA transporters (DAT) for repackaging or can remain in the extracellular space to be taken up by glial cells or metabolized by the cellular membrane.  DA may be metabolized extraneuronally by catechol-o-methyltransferase (COMT) to 3-methoxytyramine (3-MT), while monoamine oxidase-B (MAO-B) will rapidly metabolize 3-MT to homovanillic acid (HVA).[16][17] Alternatively, it may be metabolized inside the cytoplasm, where the dual action of MAO-A and aldehyde dehydrogenase (ALDH) will convert DA to the phenolic acid 3, 4-dihydroxyphenylacetic acid (DOPAC).[18]

Given this complex sequence, the modulation of dopamine can occur at various levels such as the entire neuron, its projections or the neuronal circuitry across the nervous system. In addition, during the synthesis of DA (transcriptional, translational, and post-translational regulation), synaptosomal packaging (regulation of VMAT, transport of vesicle to synapse), DA release (neuronal depolarization, calcium signaling, vesicle fusion), and via reuptake and metabolism through regulation of the respective enzymes and their spatial localization relative to their substrate.[18][19]

As indicated earlier, the systemic action of DA is mediated by varied receptors (D1, D2, D3, D4, and D5), and the alpha- and beta-adrenergic receptors. These G-coupled receptors are generally grouped into D1 or D2, primarily based on their traditional biochemical functions showing that dopamine can modulate adenylyl cyclase activity.[6][20] However, based on their molecular structure, biochemical properties and pharmacological functions DA receptors are further classified either as D1-class (D1 and D5) or D2-class (D2, D3, D4).[21][22][23][15]

Activation of the D1 receptors on smooth muscle, the proximal renal tubule, and cortical collecting duct increase diuresis.[24] D2 receptors are located pre-synaptically on the renal nerves and within the glomeruli and adrenal cortex. The activation of these nerves result in decreased renal sodium and water excretion.[25] Apomorphine is a DA receptor agonist and may have similar activation on these DA receptors.[26] Adrenergic receptors also bind DA increasing arterial smooth muscle contraction and cardiac sinoatrial node conductivity, which explains its cardiac therapeutic benefits. 

While the blood-brain barrier specifically restricts the transport of DA from the systemic circulation to the central nervous system, further research has led to the discovery of its central role in reward-seeking behavior, wherein its transmission becomes markedly increased.  Current DA research includes epigenetic changes and its involvement in a variety of psychiatric conditions including substance abuse and addiction,[27] schizophrenia and attention deficit disorder.[28] Altogether, these conditions involve disorders of the mesolimbic and mesocortical DA pathways. One common effect of addictive drugs in the CNS is the increased release of DA in the striatum, classically associated with high locomotor activity and stereotypy.[29][30] The striatal DA increase results from axon projections arising directly from the pars compacta of the substantia nigra (SN) and the ventral tegmental area (VTA), respectively,[29] which project to the nucleus accumbens and amygdala, implicated in reward-stimulation and the fear-response.[31][32] Another DA circuit, the tuberoinfundibular pathway, is mainly responsible for regulating the neuroendocrine prolactin from the anterior pituitary gland, known for its role as a lactation inducer, but also has lesser roles in water/salt homeostasis and immune response and cell-cycle regulation.[33][34] The nigrostriatal pathway is the main pathway involved in the motor deficits observed in Parkinson’s disease.[35] This pathway comprises dopaminergic neurons originating in the substantia nigra (pars compacta), and projects to the striatum via the medial forebrain bundle, forming synapses with several neuronal populations at the putamen, caudate nucleus, globus pallidus internus (GPi), and the subthalamic nucleus (STN), respectively. This elaborated network forms the afferent connections of the substantia nigra to the circuitry involved in motor movement, namely the basal ganglia. In the latter, DA plays a pivotal function controlling motor movement and in learning new motor skills.[36]

Administration

For stimulation of the sympathetic nervous system, the indication is for a continuous intravenous drip administration. DA half-life in systemic circulation is between 1 to 5 minutes, thus slower forms of administration, such as oral administration, are typically ineffective.[37]

In addition to its peripheral sympathetic effects, DA is also critical for neurological movement function in Parkinson’s disease.[35] L-DOPA administration is via the oral route, and after its absorption, a small percentage transports to the brain, where is used by the neurons in the basal ganglia. To inhibit the peripheral effects of L-DOPA in the sympathetic nervous system, it is generally administered concomitantly with carbidopa, a decarboxylase inhibitor that prevents the systemic conversion of L-DOPA to DA, which decreases the presentation of common side effects such as nausea and emesis.[38]

Adverse Effects

DA administration can adversely affect kidney function causing increased urinary flow, and irregular heartbeat, among others.[39]  Excessive administration may cause deleterious conditions such as cerebrovascular accident due to high blood pressure in the brain.[40]

As previously stated, the neurotransmitter DA also acts centrally within the mesocorticolimbic pathway and have roles in processing reward and fear, as well as focusing attention and executive functioning including complex planning.[31][32] While systemic dopamine does not cross the blood-brain barrier,[13] central dopamine has been implicated in somnolence, schizophrenia, addiction, and impulse control disorders.[27][41] Patients with neurologic conditions using high doses of L-DOPA for Parkinson’s disease may experience such physiological alterations from the dysregulation of DA within the CNS pathways.

Contraindications

In patients with conditions of the heart or circulatory system, the intravenous administration of DA is contraindicated. These conditions may include ventricular arrhythmias and tachycardia, blood vessel blockage, low blood-oxygen content, decreased blood volume, acidosis, and adrenal gland dysfunctions resulting in high blood pressure such as pheochromocytoma. For patients recently treated with monoamine oxidase inhibitors, DA is initially used in fractional doses (1/10th usual dose) and closely monitored for further effects. Medications to treat hypertension such as beta and alpha adrenergic inhibitors antagonize the therapeutic effects of DA. Haloperidol also blocks the systemic effects of DA. The anticonvulsant phenytoin has been reported to cause hypotension and decreased heart rate when used with DA. On the other hand, tricyclic antidepressants increase the DA response similar to anesthetic agents such as cyclopropane and halogenated. The use of DA in combination with oxytocin can lead to chronic hypertension and may also cause cerebrovascular accidents.[42]

Monitoring

Monitoring blood pressure and urine flow is necessary — monitoring of more advanced hemodynamic parameters such as cardiac output including rhythm and pulmonary wedge pressure is also recommended. It should be noted that DA agonists and mimetics that cross the blood-brain barrier interact with the neurological circuitry involved in motor, executive, and limbic functions including addiction-linked reward systems, impulse control mechanisms, and arousal. Thus, the cessation of DA therapies may lead to a condition called dopamine agonist withdrawal syndrome. This condition has wide-ranging symptoms including anxiety, depression, panic attacks, fatigue, hypotension, nausea, irritability, and even suicidal ideations.[43] Therefore, recommendations are to taper patients off of these centrally acting DA agonists.

Toxicity

According to "Sax's Dangerous Properties of Industrial Materials" (by Richard J. Lewis, 2004 - DOI: 10.1002/0471701343) studies in rodents showed an LD50 (a lethal dose in 50% of subjects) between 59 to 163 mg/kg. In humans, DA can lead to peripheral vasoconstriction resulting in gangrenous extremities and cardiac arrhythmias.[44][45].

Enhancing Healthcare Team Outcomes

DA administration affects the cardiovascular system among other organs, including the kidneys and the brain. Contraindications include specific pharmaceutical agents, lifestyle, and nutrition factors that can impact similar organs with DA treatment. These factors and medications include psychopharmacological agents, neuroleptics, general anesthetics, and even physical therapy-induced cardiac challenges.  Interprofessional communication is critical to ensuring proper application of DA to mitigate potentially harmful or chronic adverse effects while considering a holistic healthcare approach along with specific outcome objectives.


  • Image 6936 Not availableImage 6936 Not available
    Contribtued by NEUROtiker, CC-BY-SA 2.5 ( https://creativecommons.org/licenses/by-sa/2.5/ )
Attributed To: Contribtued by NEUROtiker, CC-BY-SA 2.5 ( https://creativecommons.org/licenses/by-sa/2.5/ )

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Dopamine - Questions

Take a quiz of the questions on this article.

Take Quiz
If a patient who has a BP of 90/60 mm Hg and little urine output, is started on renal dose dopamine. Which of the following doses should be selected?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
In certain disease states, such as hypotension, the sympathetic component of the autonomic nervous system cannot sustain normal blood pressure making necessary to artificially emulate the normal sympathetic functions of the body. Which of the following sympathomimetic drugs can target the renal blood flow and promote diuresis at low doses?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is not an effect of intravenous dopamine?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which pressor drug used at a low dose is used to increase blood flow to the renal arteries?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
What will renal blood flow do after administration of low dose dopamine?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
The breakdown of dopamine takes place by which of the following?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
How does low dose dopamine enhance renal perfusion?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Select the rate limiting enzyme for dopamine synthesis.



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 60-year-old man presents with a slow shuffling gait and muscle stiffness. He is diagnosed with Parkinson disease, which is caused by the degeneration of dopamine-producing cells. Which of the following is a precursor of dopamine?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Dopamine synthesis has which enzyme as a rate limiting step?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which treatment aims to increase systemic vascular resistance in a patient exhibiting early stages of septic shock?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
All of the following is true for dopamine except it is:



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is not a pharmacological action of intravenous dopamine?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
You are in the intensive care unit looking after a patient with a blood pressure of 90/60 mmHg and low urine output. The chief resident asks you to write an order for renal dose dopamine. Which of the following doses would you select?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A patient with dangerously low renal output presents to the emergency department. The provider orders intravenous dopamine and in short order, the patient's urine output is restored to normal levels. By what mechanism of action does dopamine primarily exert this therapeutic effect?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 66-year-old male is brought in by ambulance following a motor vehicle accident. The patient is not responsive, and his vitals in the emergency department show that he is tachycardic, tachypneic, and hypotensive. What characteristic of dopamine is an important advantage in treating this patients condition?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Dopamine - References

References

Blaschko H, The activity of l(-)-dopa decarboxylase. The Journal of physiology. 1942 Nov 30     [PubMed]
CARLSSON A,LINDQVIST M,MAGNUSSON T, 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature. 1957 Nov 30     [PubMed]
Abbott A, Neuroscience: the molecular wake-up call. Nature. 2007 May 24     [PubMed]
MONTAGU KA, Catechol compounds in rat tissues and in brains of different animals. Nature. 1957 Aug 3     [PubMed]
SANO I,GAMO T,KAKIMOTO Y,TANIGUCHI K,TAKESADA M,NISHINUMA K, Distribution of catechol compounds in human brain. Biochimica et biophysica acta. 1959 Apr     [PubMed]
Tank AW,Weiner H,Thurman JA, Enzymology and subcellular localization of aldehyde oxidation in rat liver. Oxidation of 3,4-dihydroxyphenylacetaldehyde derived from dopamine to 3,4-dihydroxyphenylacetic acid. Biochemical pharmacology. 1981 Dec 15     [PubMed]
Kopin IJ, Catecholamine metabolism: basic aspects and clinical significance. Pharmacological reviews. 1985 Dec     [PubMed]
Bhatt-Mehta V,Nahata MC, Dopamine and dobutamine in pediatric therapy. Pharmacotherapy. 1989     [PubMed]
De Backer D,Biston P,Devriendt J,Madl C,Chochrad D,Aldecoa C,Brasseur A,Defrance P,Gottignies P,Vincent JL, Comparison of dopamine and norepinephrine in the treatment of shock. The New England journal of medicine. 2010 Mar 4     [PubMed]
Hornykiewicz O, A brief history of levodopa. Journal of neurology. 2010 Nov     [PubMed]
Ghadery C,Valli M,Mihaescu A,Strafella R,Navalpotro I,Kim J,Strafella AP, Molecular Imaging of Addictive Behavior in Idiopathic Parkinson's Disease. International review of neurobiology. 2018     [PubMed]
Snyder SH, What dopamine does in the brain. Proceedings of the National Academy of Sciences of the United States of America. 2011 Nov 22     [PubMed]
Carlsson A,Kehr W,Lindqvist M,Magnusson T,Atack CV, Regulation of monoamine metabolism in the central nervous system. Pharmacological reviews. 1972 Jun     [PubMed]
Haavik J,Toska K, Tyrosine hydroxylase and Parkinson's disease. Molecular neurobiology. 1998 Jun     [PubMed]
Hardebo JE,Edvinsson L,Owman C,Rosengren E, Quantitative evaluation of the blood-brain barrier capacity to form dopamine from circulating L-DOPA. Acta physiologica Scandinavica. 1977 Mar     [PubMed]
Sibley DR,Monsma FJ Jr,Shen Y, Molecular neurobiology of dopaminergic receptors. International review of neurobiology. 1993     [PubMed]
David C,Fishburn CS,Monsma FJ Jr,Sibley DR,Fuchs S, Synthesis and processing of D2 dopamine receptors. Biochemistry. 1993 Aug 17     [PubMed]
Meiser J,Weindl D,Hiller K, Complexity of dopamine metabolism. Cell communication and signaling : CCS. 2013 May 17     [PubMed]
Seamans JK,Yang CR, The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Progress in neurobiology. 2004 Sep     [PubMed]
Meder D,Herz DM,Rowe JB,Lehéricy S,Siebner HR, The role of dopamine in the brain - lessons learned from Parkinson's disease. NeuroImage. 2018 Nov 20     [PubMed]
Mills A, Dopamine: from Cinderella to Holy Grail. Trends in pharmacological sciences. 1992 Nov     [PubMed]
Beaulieu JM,Gainetdinov RR, The physiology, signaling, and pharmacology of dopamine receptors. Pharmacological reviews. 2011 Mar     [PubMed]
Andersen PH,Gingrich JA,Bates MD,Dearry A,Falardeau P,Senogles SE,Caron MG, Dopamine receptor subtypes: beyond the D1/D2 classification. Trends in pharmacological sciences. 1990 Jun     [PubMed]
Goldberg LI, Dopamine receptors and hypertension. Physiologic and pharmacologic implications. The American journal of medicine. 1984 Oct 5     [PubMed]
Velasco M,Luchsinger A, Dopamine: pharmacologic and therapeutic aspects. American journal of therapeutics. 1998 Jan     [PubMed]
Montastruc JL,Chamontin B,Rostin M,Rascol O,Valet P,Gaillard G,Tran MA,Van TT,Ader JL,Montastruc P, Experimental and clinical approaches to treatment of hypertension by dopamine receptor agonists. Clinical and experimental hypertension. Part A, Theory and practice. 1987     [PubMed]
Feng J,Nestler EJ, Epigenetic mechanisms of drug addiction. Current opinion in neurobiology. 2013 Aug     [PubMed]
Howes OD,McCutcheon R,Owen MJ,Murray RM, The Role of Genes, Stress, and Dopamine in the Development of Schizophrenia. Biological psychiatry. 2017 Jan 1     [PubMed]
Wise RA, Addictive drugs and brain stimulation reward. Annual review of neuroscience. 1996     [PubMed]
Wise RA, Drug-activation of brain reward pathways. Drug and alcohol dependence. 1998 Jun-Jul     [PubMed]
Jellinger KA, Post mortem studies in Parkinson's disease--is it possible to detect brain areas for specific symptoms? Journal of neural transmission. Supplementum. 1999     [PubMed]
Root DH,Fabbricatore AT,Ma S,Barker DJ,West MO, Rapid phasic activity of ventral pallidal neurons during cocaine self-administration. Synapse (New York, N.Y.). 2010 Sep     [PubMed]
Grattan DR, 60 YEARS OF NEUROENDOCRINOLOGY: The hypothalamo-prolactin axis. The Journal of endocrinology. 2015 Aug     [PubMed]
Dobolyi A,Grattan DR,Stolzenberg DS, Preoptic inputs and mechanisms that regulate maternal responsiveness. Journal of neuroendocrinology. 2014 Oct     [PubMed]
Christine CW,Aminoff MJ, Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance. The American journal of medicine. 2004 Sep 15     [PubMed]
Mink JW, Basal ganglia mechanisms in action selection, plasticity, and dystonia. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. 2018 Mar     [PubMed]
Perrin G,Papazian L,Martin C, [Dopexamine: a new dopaminergic agonist]. Annales francaises d'anesthesie et de reanimation. 1993     [PubMed]
Gilbert JA,Frederick LM,Ames MM, The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Clinical cancer research : an official journal of the American Association for Cancer Research. 2000 Nov     [PubMed]
Stoker TB,Torsney KM,Barker RA, Emerging Treatment Approaches for Parkinson's Disease. Frontiers in neuroscience. 2018     [PubMed]
De Vecchis R,Ciccarelli A,Pucciarelli A, Unloading therapy by intravenous diuretic in chronic heart failure: a double-edged weapon? Journal of cardiovascular medicine (Hagerstown, Md.). 2010 Aug     [PubMed]
Cho JR,Treweek JB,Robinson JE,Xiao C,Bremner LR,Greenbaum A,Gradinaru V, Dorsal Raphe Dopamine Neurons Modulate Arousal and Promote Wakefulness by Salient Stimuli. Neuron. 2017 Jun 21     [PubMed]
Kittner SJ,Stern BJ,Feeser BR,Hebel R,Nagey DA,Buchholz DW,Earley CJ,Johnson CJ,Macko RF,Sloan MA,Wityk RJ,Wozniak MA, Pregnancy and the risk of stroke. The New England journal of medicine. 1996 Sep 12     [PubMed]
Yu XX,Fernandez HH, Dopamine agonist withdrawal syndrome: A comprehensive review. Journal of the neurological sciences. 2017 Mar 15     [PubMed]
Colak T,Erdogan O,Yerebakan O,Arici C,Gurkan A, Symmetrical peripheral gangrene and dopamine. Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES. 2003 Jul     [PubMed]
Gelfman DM,Ornato JP,Gonzalez ER, Dopamine-induced increase in atrioventricular conduction in atrial fibrillation-flutter. Clinical cardiology. 1987 Nov     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Surgery-Urologic. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Surgery-Urologic, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Surgery-Urologic, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Surgery-Urologic. When it is time for the Surgery-Urologic board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Surgery-Urologic.